Related Experiment Video

Updated: Jul 6, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.0K

Editorial: Novel CNS targeting molecules, methods, and therapeutics in multiple sclerosis

Rune Alexander Aamodt Høglund1, Stella E Tsirka2, Makoto Inoue3

  • 1Department of Neurology, Akershus University Hospital, Lørenskog, Norway.

Frontiers in Immunology
|October 6, 2025
PubMed
Summary

No abstract available in PubMed .

Keywords:
CNS therapeuticsbiomarkerdiagnostic methodneurogenesisneuronal progenitor cellsoligodedrocyte progenitor cellsremyelination

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.9K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...